IHS Chemical Week

People & Business :: M&A

Swiss health-care group Galenica to split into two listed companies

9:33 AM MDT | August 12, 2014 | Natasha Alperowicz

Galenica (Bern, Switzerland) said today that it is adapting a new management structure. The group will be headed by two CEOs, one in charge of Vifor Pharma, formerly the pharma division, and one of Gelenica Santé, the former Santé division. Both CEOs will report directly to the executive chairman. The role of CEO Galenica Group is being abolished. With this move, the board is creating the best conditions for both the Vifor Pharma and Galenica Santé units to prepare to become listed, independent companies when the time is right, the company...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa